Advanced Therapies Week – Miami, Florida

Breakfast Symposium

Date/Time: January 17, 8:00 a.m. – 9:00 a.m. EST
Title: A disruptive approach to advancement – Strategic investments and collaborative innovation to solve major manufacturing pain points

Speakers:

• Gianluca Pettiti, Executive Vice President, Thermo Fisher Scientific
• Xavier de Mollerat due Jeu, Sr. Director of R&D, Thermo Fisher Scientific
• Andy Campbell, Sr. Director of R&D, Thermo Fisher Scientific

Description:
The range of new tools and technologies available to cell therapy manufacturers has seen a dramatic expansion over the past decade. Biotechnology developers have focused on developing solutions to address both the physical manufacturing challenges and the underlying physiologic factors that affect therapeutic efficacy, which has helped to fuel a robust clinical cell therapy pipeline.

In this symposium, you will hear industry leaders discuss:

• Thermo Fisher Scientific’s cell therapy portfolio of tools and instruments, and how they can be incorporated into an end-to-end, closed, scalable and automatable workflow
• The first cGMP cell selection technology to have an active release mechanism, allowing for increased control over target cell isolation and activation while simultaneously providing process flexibility for downstream steps
• Benefits gained from automating, scaling, and integrating your manufacturing process and how strategic collaborations can help advance the field